Literature DB >> 25605858

When is good enough really good enough? Defining the role of radiation in low-risk ductal carcinoma in situ.

Benjamin D Smith1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25605858     DOI: 10.1200/JCO.2014.59.4259

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN: 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  4 in total

1.  Women with Low-Risk DCIS Eligible for the LORIS Trial After Complete Surgical Excision: How Low Is Their Risk After Standard Therapy?

Authors:  Melissa Pilewskie; Cristina Olcese; Sujata Patil; Kimberly J Van Zee
Journal:  Ann Surg Oncol       Date:  2016-10-20       Impact factor: 5.344

2.  Risk prediction for local versus regional/metastatic tumors after initial ductal carcinoma in situ diagnosis treated by lumpectomy.

Authors:  Annette M Molinaro; Jennette D Sison; Britt-Marie Ljung; Thea D Tlsty; Karla Kerlikowske
Journal:  Breast Cancer Res Treat       Date:  2016-05-04       Impact factor: 4.872

Review 3.  Radiotherapy of Ductal Carcinoma In Situ.

Authors:  David Krug; Rainer Souchon
Journal:  Breast Care (Basel)       Date:  2015-08-19       Impact factor: 2.860

4.  Single-cell heterogeneity in ductal carcinoma in situ of breast.

Authors:  Michael J Gerdes; Yesim Gökmen-Polar; Yunxia Sui; Alberto Santamaria Pang; Nicole LaPlante; Adrian L Harris; Puay-Hoon Tan; Fiona Ginty; Sunil S Badve
Journal:  Mod Pathol       Date:  2017-11-17       Impact factor: 7.842

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.